Profile of ipragliflozin for treating type 2 diabetes

[ad_1] Introduction Type 2 diabetes mellitus (T2D) is a metabolic disorder that results from pancreatic beta…

LRRK2 gene and type 2 diabetes on neurodegenerative diseases

[ad_1] Mei-Hsuen Huang,1 Yu-Fan Liu,2,3 Oswald Ndi Nfor,4 Shu-Yi Hsu,4 Wei-Yong Lin,5– 7 Yuan-Shiun Chang,1 Yung-Po…

Adipose tissue biomarkers and type 2 diabetes incidence in normoglycemic participants in the MESArthritis Ancillary Study: A cohort study

[ad_1] Abstract Background Given the central role of skeletal muscles in glucose homeostasis, deposition of adipose…

Nutritional basis of type 2 diabetes remission

[ad_1] Roy Taylor, professor1 , Ambady Ramachandran, professor2 3, William S Yancy Jr, physician4, Nita G…

Nerve Conduction and Ofactory Tests in Type Two Diabetes

[ad_1] Introduction The increase in the size of the global aging population and the prevalence of…

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

[ad_1] Summary Background Type 1 diabetes results from autoimmune-mediated destruction of β cells. The tyrosine kinase…

Bring Type 1 Diabetes in Adults Out of the Shadows

[ad_1] A new draft consensus statement from the American Diabetes Association (ADA) and the European Association…

Non-MHC genes and autoimmune thyroiditis in type 1 diabetes

[ad_1] Introduction Type 1 diabetes (T1D) is characterized by a severe autoimmune pancreatic β-cell destruction, usually…

Lipophagy in type 2 diabetes mellitus treatment – DMSO

[ad_1] Introduction Type 2 diabetes mellitus (T2DM) is a complex metabolic disease with a high incidence…

Dual inhibitor provides benefits in type 2 diabetes and heart failure, CKD

[ad_1] Source/Disclosures Published by: Source: Bhatt DL, et al. 3-CT-SY24. Presented at: American Diabetes Association…